26Aug
Financial Daily Dose 8.26.2019 | Top Story: Amgen to Pay More Than $13 Billion for Otezla
Amgen will pay $13.4 billion in cash to buy psoriasis treatment Otezla, a deal that will “pave the way for Bristol-Myers Squibb to complete its acquisition of Celgene” by addressing “regulatory concerns over their union”....
By:
Robins Kaplan LLP
Related
Last week, the U.S. Department of Labor’s Wage and Hour Division adopted final regulations revising...
Read More >
A recent Scottish case considers the contractual power to omit works and highlights key principles a...
Read More >
The Texas Workforce Commission (“TWC”), the agency responsible for administering unemployment bene...
Read More >
A recent decision by the Third District Court of Appeals has engendered uncertainty about the manner...
Read More >
As a result of developments relating to the COVID-19 coronavirus pandemic, the Premerger Notificatio...
Read More >
In its first installment of opinions letters in 2020, the U.S. Department of Labor’s Wage and Hour ...
Read More >